We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B Turnover 16.03%
1-Year Est. Return 42.52%
 

Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.

This Fund
S&P 500
This Quarter Est. Return
+23.97%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.28%
AUM
$69.6B
AUM Growth
+$8.07B
Cap. Flow
+$567M
Cap. Flow %
0.82%
Top 10 Hldgs %
16.2%
Holding
2,221
New
173
Increased
863
Reduced
913
Closed
183
Avg Time Held
5.7 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$436M
2
RF icon
Regions Financial
RF
+$313M
3
ADP icon
Automatic Data Processing
ADP
+$289M
4
INTU icon
Intuit
INTU
+$288M
5
NFLX icon
Netflix
NFLX
+$253M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Healthcare 13.59%
3 Industrials 13.09%
4 Financials 10.33%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
REPX icon
1851
Riley Exploration Permian
REPX
$1.18B
$10.1K ﹤0.01%
+305
New +$10.9K
2026 Q2
0 quarters
HYMC icon
1852
Hycroft Mining Holding Corp
HYMC
$1.53B
$10K ﹤0.01%
429
+3
+0.7% +$101
2025 Q3
3 quarters
RAPP icon
1853
Rapport Therapeutics
RAPP
$1.2B
$10K ﹤0.01%
240
+97
+68% +$3.56K
2025 Q4
2 quarters
STN icon
1854
Stantec
STN
$8.13B
$9.9K ﹤0.01%
144
-53
-27% -$4.27K
2025 Q4
2 quarters
ANIK icon
1855
Anika Therapeutics
ANIK
$280M
$9.9K ﹤0.01%
675
+55
+9% +$815
2025 Q3
3 quarters
RUSHA icon
1856
Rush Enterprises Class A
RUSHA
$5.02B
$9.9K ﹤0.01%
+203
New +$9.6K
2026 Q2
0 quarters
SGHT icon
1857
Sight Sciences
SGHT
$513M
$9.8K ﹤0.01%
1,816
-397
-18% -$1.83K
2026 Q1
1 quarter
FOSL icon
1858
Fossil Group
FOSL
$393M
$9.8K ﹤0.01%
2,370
+853
+56% +$3.82K
2025 Q3
3 quarters
UNIT icon
1859
Uniti Group
UNIT
$1.23B
$9.6K ﹤0.01%
841
+95
+13% +$1.08K
2020 Q2
24 quarters
BCPC icon
1860
Balchem Corp
BCPC
$5.42B
$9.6K ﹤0.01%
57
-214
-79% -$35.5K
2024 Q4
6 quarters
FNKO icon
1861
Funko
FNKO
$357M
$9.49K ﹤0.01%
+1,614
New +$7.76K
2026 Q2
0 quarters
PLPC icon
1862
Preformed Line Products
PLPC
$1.42B
$9.03K ﹤0.01%
22
-3
-12% -$1.05K
2017 Q1
37 quarters
PYXS icon
1863
Pyxis Oncology
PYXS
$151M
$8.92K ﹤0.01%
2,962
-219
-7% -$419
2025 Q4
2 quarters
BAND icon
1864
Bandwidth Inc
BAND
$1.53B
$8.8K ﹤0.01%
+139
New +$6.24K
2026 Q2
0 quarters
CCCC icon
1865
C4 Therapeutics
CCCC
$415M
$8.77K ﹤0.01%
1,878
– –
2026 Q1
1 quarter
CVLG icon
1866
Covenant Logistics
CVLG
$785M
$8.75K ﹤0.01%
198
+4
+2% +$146
2017 Q4
34 quarters
CWBC icon
1867
Community West Bancshares
CWBC
$700M
$8.43K ﹤0.01%
+314
New +$7.64K
2026 Q2
0 quarters
QUAD icon
1868
Quad
QUAD
$371M
$8.33K ﹤0.01%
988
+224
+29% +$1.68K
2013 Q2
52 quarters
FATE icon
1869
Fate Therapeutics
FATE
$249M
$8.14K ﹤0.01%
3,015
– –
2025 Q3
3 quarters
UTL icon
1870
Unitil
UTL
$1.01B
$8.06K ﹤0.01%
+153
New +$7.94K
2026 Q2
0 quarters
CURV icon
1871
Torrid Holdings
CURV
$243M
$7.93K ﹤0.01%
+4,240
New +$7.41K
2026 Q2
0 quarters
MKL icon
1872
Markel Group
MKL
$22.9B
$7.81K ﹤0.01%
4
+3
+300% +$5.6K
2016 Q2
40 quarters
ROP icon
1873
Roper Technologies
ROP
$46.1B
$7.78K ﹤0.01%
23
-88
-79% -$30K
2013 Q2
52 quarters
DTI icon
1874
Drilling Tools International
DTI
$56.5M
$7.62K ﹤0.01%
3,948
+3,765
+2,057% +$11.2K
2026 Q1
1 quarter
FISI icon
1875
Financial Institutions
FISI
$776M
$7.48K ﹤0.01%
+192
New +$6.82K
2026 Q2
0 quarters

Similar funds

Federated Hermes's Q2 2026 Portfolio in Review

As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
  • Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
  • Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
  • Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
  • Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
  • Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.